Price$319.74-26.15 (-7.56%)
2026-04-142026-07-17
News · 26 weeks90-40%
2026-01-252026-07-19
Mix3490d
- Insider15(44%)
- Other11(32%)
- SEC Filings5(15%)
- Earnings1(3%)
- Dividends1(3%)
- M&A1(3%)
Latest news
25 items- PRStryker expands Mako robotics portfolio with full market release of Mako RPSNew handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic marketStryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures.The launch introduces Mako Handheld Robotics, expanding the Mako portfolio beyond robotic-arm assisted surgery.Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.PORTAGE, Mich., July 16, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement pro
- ANALYSTBMO Capital Markets initiated coverage on Stryker with a new price targetBMO Capital Markets initiated coverage of Stryker with a rating of Outperform and set a new price target of $369.00
- PRStryker to announce second quarter 2026 financial resultsPortage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast. About Stryker Stryker is a global leader in medical technologies and
- SECStryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - STRYKER CORP (0000310764) (Filer)
- PRStryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacementPORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand ambassador for its Joint Replacement division. Through this collaboration, Lowry will share a deeply personal story, highlighting the critical role caregivers play in supporting loved ones through joint pain, surgery and recovery. As a caregiver to his father, Brendan, a former Gaelic football p
- PRFresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma FirepowerIssued on behalf of Conexeu Sciences Inc.A clutch of new directors with Fortune 500 finance, M&A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.RENO, Nev., June 16, 2026 /CNW/ -- American News Group News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a promising platform into a real business. The names a young company recruits in that window say a great deal about its ambitions. On June 1
- INSIDERPresident and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker launches TPX HD® power tool, supporting demanding orthopaedic proceduresPORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures. "Revision procedures are some of the most demanding cases surgeons face, especially when metal cutting is involved," said Mike Carlin, president of Stryker's Ortho Tech division. "TPX HD was designed with tho
- INSIDERVP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker Launches Pangea Plating System and Completes First Case in EuropeStryker (NYSE:SYK), a global leader in medical technologies, announced today the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns. Prof. Alex Trompeter, design surgeon and orthopaedic trauma surgeon, along with his team at St. George's University Hospital in London, completed the first clinical case in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525326817/en/Stryker's Pangea Plating System brings together thoughtfully designed plates and a streamlined instrumentation set, giving surgeons practical options when treating a range of fractures. "Pan
- SECSEC Form SD filed by Stryker CorporationSD - STRYKER CORP (0000310764) (Filer)
- SECSEC Form 8-K filed by Stryker Corporation8-K - STRYKER CORP (0000310764) (Filer)
- PRBioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech EcosystemThree companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in the expansion of its peripheral vascular portfolio. All three companies have close t
- INSIDERVP, Chief HR Officer Fink M Kathryn exercised 21,582 shares at a strike of $167.98, covered exercise/tax liability with 16,362 shares and sold $2,473,756 worth of shares (8,720 units at $283.69) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- SECSEC Form 10-Q filed by Stryker Corporation10-Q - STRYKER CORP (0000310764) (Filer)
- INSIDERDirector Suri Rajeev was granted 762 shares, increasing direct ownership by 12% to 7,190 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E was granted 762 shares, increasing direct ownership by 136% to 1,322 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Skeete Tatum Lisa M was granted 762 shares, increasing direct ownership by 17% to 5,205 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Silvernail Andrew K was granted 762 shares, increasing direct ownership by 4% to 18,465 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Ruggeri Rachel was granted 762 shares, increasing direct ownership by 62% to 2,001 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Mccoy Sherilyn S was granted 762 shares, increasing direct ownership by 12% to 7,190 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Maceda Emmanuel Perez was granted 762 shares, increasing direct ownership by 136% to 1,322 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Caforio Giovanni was granted 762 shares, increasing direct ownership by 20% to 4,530 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Brainerd Mary K was granted 762 shares, increasing direct ownership by 11% to 7,790 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
SYK FAQ
7 questionsWhat does Stryker Corporation do?
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various...Where does SYK stock trade?
Stryker Corporation (SYK) is listed on NYSE.What sector and industry is SYK in?
Stryker Corporation operates in the Health Care sector, Medical/Dental Instruments industry.Does SYK pay a dividend?
SYK's most recent ex-dividend date was 2026-06-30 with a cash dividend of $0.88 per share. No future ex-date is on file yet.What are analysts saying about SYK?
Stryker Corporation has had 8 recent analyst actions on file. The most recent action was from BMO Capital Markets: Outperform on 2026-07-09.What companies are similar to SYK?
Notable peers in the same industry include JNJ (Johnson & Johnson), MDT (Medtronic plc.), BDX (Becton Dickinson and Company), ZBH (Zimmer Biomet Holdings Inc.), BAX (Baxter International Inc.). Compare SYK side-by-side with any of them on Quantisnow.How can I track SYK on Quantisnow?
Quantisnow aggregates Stryker Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SYK to receive live email and push alerts on every new disclosure.